PMID- 33732326 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210320 IS - 1792-0981 (Print) IS - 1792-1015 (Electronic) IS - 1792-0981 (Linking) VI - 21 IP - 4 DP - 2021 Apr TI - Differentiation of HL-60 cells in serum-free hematopoietic cell media enhances the production of neutrophil extracellular traps. PG - 353 LID - 10.3892/etm.2021.9784 [doi] LID - 353 AB - Neutrophil extracellular traps (NETs) are web-like structures made of chromatin and have been identified to have a role in the host's immune defense. Differentiated human promyelocytic leukemia HL-60 cells (dHL-60) have been used to study the mechanisms of NETs formation, as neutrophils have a short lifespan that limits their use. However, dHL-60 cells are inefficient at generating NETs and therefore are not ideal replacements for neutrophils in studying of NET formation. In the present study, the optimal cell culture conditions and differentiation time that result in the most effective release of NETs from dHL-60 cells upon stimulation were determined. HL-60 cells were cultured in serum (FBS) or serum-free (X-VIVO) medium and differentiated using all-trans retinoic acid (ATRA) or dimethyl sulfoxide (DMSO). dHL-60 cells were stimulated with phorbol 12-myristate 13-acetate (PMA) or Ca(2+) ionophore (CI). Cell differentiation and apoptosis, as well as the formation of reactive oxygen species (ROS) and citrullinated histone H3 (citH3) were analyzed using flow cytometry. NETs were visualized using fluorescence microscopy and NET quantification was performed using PicoGreen. Induction of HL-60 cells for five days produced the best results in terms of differentiation markers and cell viability. Both ATRA- and DMSO-induced dHL-60 cells were able to release NETs upon PMA and CI stimulation; dHL-60 cells in serum-free medium produced more NETs than those in serum-containing medium. DMSO-dHL-60 (X-VIVO) cells were most efficient at producing NETs and ROS upon stimulation with PMA, while ATRA-dHL-60 (X-VIVO) cells were most efficient at producing NETs and citH3 upon stimulation with CI. It was concluded that DMSO-dHL-60 (X-VIVO) may be a model for the study of ROS-high NETosis and ATRA-dHL-60 (X-VIVO) may be suitable for ROS-low NETosis. CI - Copyright: (c) Guo et al. FAU - Guo, Yun AU - Guo Y AD - Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Gao, Fei AU - Gao F AD - Department of Intensive Care Unit, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Wang, Qian AU - Wang Q AD - Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Wang, Kang AU - Wang K AD - Department of Laboratory, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Pan, Shanshan AU - Pan S AD - Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Pan, Zhenzhen AU - Pan Z AD - Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Xu, Shiyao AU - Xu S AD - Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Li, Ling AU - Li L AD - Department of Respiratory Medicine, The Affiliated Wuxi Children's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. FAU - Zhao, Deyu AU - Zhao D AD - Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China. LA - eng PT - Journal Article DEP - 20210211 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC7903455 OTO - NOTNLM OT - HL-60 OT - all-trans retinoic acid OT - cell differentiation OT - dimethyl sulfoxide OT - histone citrullination OT - neutrophil OT - neutrophil extracellular traps OT - reactive oxygen species OT - serum-free medium COIS- The authors declare that they have no competing interests. EDAT- 2021/03/19 06:00 MHDA- 2021/03/19 06:01 PMCR- 2021/02/11 CRDT- 2021/03/18 06:48 PHST- 2020/04/17 00:00 [received] PHST- 2020/10/28 00:00 [accepted] PHST- 2021/03/18 06:48 [entrez] PHST- 2021/03/19 06:00 [pubmed] PHST- 2021/03/19 06:01 [medline] PHST- 2021/02/11 00:00 [pmc-release] AID - ETM-0-0-09784 [pii] AID - 10.3892/etm.2021.9784 [doi] PST - ppublish SO - Exp Ther Med. 2021 Apr;21(4):353. doi: 10.3892/etm.2021.9784. Epub 2021 Feb 11.